Navigation Links
Synedgen Announces Effective Treatment Against Bacterial Biofilms in Minor Animal Species
Date:5/5/2013

Claremont CA (PRWEB) May 05, 2013

Removing embedded bacteria from biofilms in wounds remains a challenge to doctors and caregivers. Likewise, veterinarians face similar challenges treating their zoo patients. Synedgen will report compelling data on new treatments against wound biofilms at a poster session at the 113th General Meeting of the American Society for Microbiology (asm2013) on May 18-21, 2013, at the Colorado Convention Center in Denver Colorado.

The poster, Antibacterial and Wound Healing Enhancement of PAAG in Minor Species, highlights the antibacterial and biofilm-reducing activity of Synedgen’s Synoplex® rinse. Data will be presented for efficacy against bacteria from elephant wounds and for Klebsiella pneumoniae biofilms. Data from additional collaborative studies evaluating Synoplex in the treatment of chronic elephant and rhinoceros wounds, including foot-disease, pressure ulcers, and infected glands that were not responding well to conventional treatment will also be presented. Synoplex is approved for marketing by the FDA as a treatment for wounds in elephants and rhinoceros.

Bacteria isolated from elephant wounds were all reduced more than 1000 fold after 1-hour treatment with Synoplex. K. pneumonia biofilms were reduced by more than 1000 fold after 5-hour treatment. Epithelial cells, which are responsible for the initial stages of regeneration of tissue, grew to cover at least twice more surface area than other wound treatments and control. Treated minor species showed significant improvement in wound healing and successful resolution of most wounds.
Synedgen’s VP of Research Stacy Townsend PhD will present the results on Tuesday May 21, 2013 at 1:00 PM - 2:45 PM at Poster board # 2194.

“As demonstrated by these studies, Synoplex provides a highly effective prophylactic and therapeutic treatment for controlling and preventing bacterial biofilms associated with chronic and acute dermal wounds including foot disease in minor species,” remarked Townsend. “The non-toxic nature of Synoplex is also beneficial in a large animal setting.”

Synoplex is available directly from Synedgen. For pricing and ordering information, please contact Synedgen at info(at)synedgen(dot)com.

About Synedgen

Synedgen Inc. is an innovative biopharmaceutical company focused on developing novel therapies and products through its proprietary biomaterials technology platform. Product development is targeted to specifically address unmet needs for therapies to treat inflammation, damage or infection at dermal, pulmonary and gastrointestinal surfaces.

Synedgen’s Corporate Headquarters, Research Laboratories and Manufacturing Facility are in Claremont CA. Additional information can be found at Synedgen’s web site at http://www.synedgen.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10700553.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Synedgen Announces Issuance of Patent to Optimize Animal Health
2. Synedgen’s Synoplex® Receives FDA Indexing for Use in the Treatment of Chronic Wounds in Pachyderms
3. Small Business Online SEO Class Enrolling Now, Announces JM Internet
4. Anthera Announces First Quarter 2013 Financial Report and Conference Call
5. Life Technologies Announces First Quarter 2013 Results
6. ETEX Corporation announces extended Supply Agreement with Knee Creations, LLC
7. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
8. BioLife Solutions Announces License Agreement
9. PRIM&R Announces Longtime Leader to Step Down
10. MiMedx Announces Record First Quarter 2013 Results
11. ViroPharma Announces First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 2016 , ... Cenna Bioscience Inc., an emerging biopharmaceutical company focused on the ... it has been selected to present at the Cavendish Global Health Impact Forum taking ... The purpose of the Forum is to help family offices and foundations develop and ...
(Date:2/9/2016)... , ... February 09, 2016 , ... With a presidential ... Wharton Health Care Business Conference will bring together over 500 top healthcare leaders for ... industry in transformation. The conference, organized by MBA students of the University of Pennsylvania’s ...
(Date:2/9/2016)... , ... February 08, 2016 , ... ... , Location: Baruch S. Blumberg Institute at the Pennsylvania Biotechnology Center of Bucks ... Institute and The Commonwealth Medical College (TCMC) will hold an open house for ...
(Date:2/9/2016)... CA (PRWEB) , ... February 09, 2016 , ... ... present its latest innovations on its free and validated Electronic Data Capture (EDC) ... #81 the Outsourcing in Clinical Trials West Coast 2016 Conference in San Mateo, ...
Breaking Biology Technology:
(Date:2/3/2016)... Vigilant Solutions announces today that the ... Missouri solved two recent hit-and-run cases with ... Vigilant Solutions. Brian Wenberg explains, "I ... was walking out of a convenience store and witnessed an elderly male back ... striking his vehicle and leaving the scene.  In his ...
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/2/2016)... 2016   Parabon NanoLabs (Parabon) announced ... Research Office and the Defense Forensics and Biometrics ... the company,s Snapshot Kinship Inference software ... generally, defense-related DNA forensics.  Although Snapshot is best ... and ancestry from DNA evidence), it also has ...
Breaking Biology News(10 mins):